Stefanetti

Journal Pre-proof Phase II feasibility study of the efficacy, tolerability and impact on the gut microbiome of a low residue (fibre) diet in adult patients with mitochondrial disease.

M. Jackson, D. Turnbull, C. Lamb, 2022 .